Barely Significant
← all excerpts

Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth.

Oncoimmunology · 2018 · PMC6140584 · PMID 30228950

Europe PMCDOI
1
hedged sentence
0.0555
closest p · 1.1× alpha
0.0555
boldest claim

The sentences

did not reach statistical significancep = 0.0555so close (0.05 < p ≤ 0.1)
The metastatic tumor area was lower with RON i treatment, but this difference did not reach statistical significance ( Figure 5b ; p = 0.0555).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.